My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Premier, Inc. - Class A Common Stock (NQ:PINC)

28.26 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Premier, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)

March 14, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

3 Value Stocks in Hot Water

March 12, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

3 Reasons to Sell PINC and 1 Stock to Buy Instead

March 04, 2025

Over the past six months, Premier’s shares (currently trading at $17.93) have posted a disappointing 13.5% loss, well below the S&P 500’s 6.2% gain. This was partly driven by its softer quarterly...

Via StockStory

Topics Economy Stocks

Astrana Health (ASTH) To Report Earnings Tomorrow: Here Is What To Expect

February 26, 2025

Healthcare services company Astrana Health will be reporting results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Unveiling 5 Analyst Insights On Premier ↗

November 06, 2024

Via Benzinga

Assessing Premier: Insights From 4 Financial Analysts ↗

October 02, 2024

Via Benzinga

NASDAQ:PINC: good value for what you're paying. ↗

September 05, 2024

PREMIER INC-CLASS A (NASDAQ:PINC) is probably undervalued for the fundamentals it is displaying.

Via Chartmill

Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

GoodRx Earnings: What To Look For From GDRX

February 26, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know.

Via StockStory

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

February 25, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Via StockStory

Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect

February 23, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know.

Via StockStory

Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For

February 19, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect.

Via StockStory

Decoding 4 Analyst Evaluations For Premier ↗

May 28, 2024

Via Benzinga

Unveiling 4 Analyst Insights On Premier ↗

May 08, 2024

Via Benzinga

NASDAQ:PINC, an undervalued stock with good fundamentals. ↗

November 21, 2023

PREMIER INC-CLASS A (NASDAQ:PINC), an undervalued stock with good fundamentals.

Via Chartmill

Waystar (WAY) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 17, 2025

Healthcare technology company Waystar Holding (NASDAQ:WAY) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

Earnings To Watch: Omnicell (OMCL) Reports Q4 Results Tomorrow

February 05, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect.

Via StockStory

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday? ↗

February 04, 2025

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

Via Benzinga

Why Premier (PINC) Shares Are Sliding Today

February 04, 2025

Shares of healthcare tech company Premier (NASDAQ:PINC) fell 14.3% in the afternoon session after the company reported weak fourth-quarter results, with its revenue and EPS falling short of Wall...

Via StockStory

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

February 04, 2025

Via Benzinga

Premier (NASDAQ:PINC) Reports Sales Below Analyst Estimates In Q4 Earnings

February 04, 2025

Healthcare tech company Premier (NASDAQ:PINC) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 28.2% year on year to $240.3 million. The company’s full-year revenue guidance...

Via StockStory

Topics Economy

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

October 21, 2024

Via Benzinga

Earnings Scheduled For February 4, 2025 ↗

February 04, 2025

Via Benzinga

PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q4 2024 ↗

August 20, 2024

PINC stock results show that Premier beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.

Via InvestorPlace

PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q3 2024 ↗

May 07, 2024

PINC stock results show that Premier beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗

February 14, 2024

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

Via Benzinga

Healthcare Purchasing Network Premier Launches $1B Share Buyback Program, Concludes Strategic Review Process After Q2 Performance ↗

February 06, 2024

Premier charts a strategic path with a $1.0 billion share repurchase plan through June 2025. Q2 2024 earnings: EPS $0.60, sales $334.75 million

Via Benzinga

7 Dividend-Paying Healthcare Stocks for Income Investors ↗

December 06, 2023

With the global markets presenting an ambiguous framework, investors may find confidence in dividend paying healthcare stocks.

Via InvestorPlace

Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio ↗

December 01, 2023

Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need.

Via InvestorPlace

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields ↗

November 27, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.